George DJ - Search Results

1

Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report.

McNamara MA, George DJ. McNamara MA, et al. Among authors: george dj. BMC Cancer. 2015 May 7;15:371. doi: 10.1186/s12885-015-1390-y. BMC Cancer. 2015. PMID: 25948240 Free PMC article.

2

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.

Oh WK, George DJ, Kantoff PW. Oh WK, et al. Among authors: george dj. Cancer. 2002 Feb 1;94(3):686-9. doi: 10.1002/cncr.10269. Cancer. 2002. PMID: 11857300 Free article.

3

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, Small EJ, Kantoff PW. George DJ, et al. Clin Cancer Res. 2005 Mar 1;11(5):1815-20. doi: 10.1158/1078-0432.CCR-04-1560. Clin Cancer Res. 2005. PMID: 15756004

4

New drug development in metastatic prostate cancer.

Armstrong AJ, George DJ. Armstrong AJ, et al. Among authors: george dj. Urol Oncol. 2008 Jul-Aug;26(4):430-7. doi: 10.1016/j.urolonc.2007.11.006. Urol Oncol. 2008. PMID: 18593623 Review.

5

A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer.

Armstrong AJ, Creel P, Turnbull J, Moore C, Jaffe TA, Haley S, Petros W, Yenser S, Gockerman JP, Sleep D, Hurwitz H, George DJ. Armstrong AJ, et al. Among authors: george dj. Clin Cancer Res. 2008 Oct 1;14(19):6270-6. doi: 10.1158/1078-0432.CCR-08-1085. Clin Cancer Res. 2008. PMID: 18829508 Clinical Trial.

6

The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival.

Armstrong AJ, Tannock IF, de Wit R, George DJ, Eisenberger M, Halabi S. Armstrong AJ, et al. Among authors: george dj. Eur J Cancer. 2010 Feb;46(3):517-25. doi: 10.1016/j.ejca.2009.11.007. Epub 2009 Dec 11. Eur J Cancer. 2010. PMID: 20005697 Clinical Trial.

7

Clinical roundtable monograph: new and emerging treatments for advanced prostate cancer.

George DJ, Kantoff PW, Lin DW. George DJ, et al. Clin Adv Hematol Oncol. 2011 Jun;9(6):1-11; discussion 11-5. Clin Adv Hematol Oncol. 2011. PMID: 21941983 Review.

8

New and emerging treatments for advanced prostate cancer.

George DJ, Kantoff PW, Lin DW. George DJ, et al. Clin Adv Hematol Oncol. 2011 Jun;9(6 Suppl 12):1-15. Clin Adv Hematol Oncol. 2011. PMID: 22361744 Review.

9

Activity of single-agent bevacizumab in patients with metastatic renal cell carcinoma previously treated with vascular endothelial growth factor tyrosine kinase inhibitors.

Turnbull JD, Cobert J, Jaffe T, Harrison MR, George DJ, Armstrong AJ. Turnbull JD, et al. Among authors: george dj. Clin Genitourin Cancer. 2013 Mar;11(1):45-50. doi: 10.1016/j.clgc.2012.06.001. Epub 2012 Oct 4. Clin Genitourin Cancer. 2013. PMID: 23041453

10

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease.

Harrison MR, Wong TZ, Armstrong AJ, George DJ. Harrison MR, et al. Among authors: george dj. Cancer Manag Res. 2013;5:1-14. doi: 10.2147/CMAR.S25537. Epub 2013 Jan 8. Cancer Manag Res. 2013. PMID: 23326203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters